第1巻 2005年6月　第3号

■臨床医のために

心房細動と脳血栓・塞栓症予防
本間　博
日本医科大学内科学第一

Antithrombotic Therapy in Atrial Fibrillation
Hiroshi Honma
First Department of Internal Medicine, Nippon Medical School

One of the most clinically important objectives of therapy for atrial fibrillation is the prevention of stroke/thromboembolism. The risk of ischemic stroke in patients with atrial fibrillation may be related to multifactorial pathogenesis. The only therapy for atrial fibrillation with the effect of reducing mortality is anticoagulation with warfarin, not antiarrhythmic therapy. However, the management of atrial fibrillation includes a lot of modulating factors and should be carefully carried out on a case-by-case basis.

日医大医会誌 2005; 1(3), 129-134

Key words
atrial fibrillation, ischemic stroke, antithrombotic therapy, warfarin, aspirin

Correspondence to
Hiroshi Honma, M.D., First Department of Internal Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan

受付：2005年2月28日　受理：2005年5月13日